Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 25 to 36 of 1829 entries
Sorted by: Best Match Show Resources per page
Strong binary pulsar constraints on Lorentz violation in gravity.

Physical review letters

Yagi K, Blas D, Yunes N, Barausse E.
PMID: 24815632
Phys Rev Lett. 2014 Apr 25;112(16):161101. doi: 10.1103/PhysRevLett.112.161101. Epub 2014 Apr 24.

Binary pulsars are excellent laboratories to test the building blocks of Einstein's theory of general relativity. One of these is Lorentz symmetry, which states that physical phenomena appear the same for all inertially moving observers. We study the effect...

Cite
Yagi K, Blas D, Yunes N, et al. Strong binary pulsar constraints on Lorentz violation in gravity. Phys Rev Lett. 2014;112(16):161101doi: 10.1103/PhysRevLett.112.161101.
Yagi, K., Blas, D., Yunes, N., & Barausse, E. (2014). Strong binary pulsar constraints on Lorentz violation in gravity. Physical review letters, 112(16), 161101. https://doi.org/10.1103/PhysRevLett.112.161101
Yagi, Kent, et al. "Strong binary pulsar constraints on Lorentz violation in gravity." Physical review letters vol. 112,16 (2014): 161101. doi: https://doi.org/10.1103/PhysRevLett.112.161101
Yagi K, Blas D, Yunes N, Barausse E. Strong binary pulsar constraints on Lorentz violation in gravity. Phys Rev Lett. 2014 Apr 25;112(16):161101. doi: 10.1103/PhysRevLett.112.161101. Epub 2014 Apr 24. PMID: 24815632.
Copy Download .nbib Format: NLM
Entire Sound Representations Are Time-Compressed in Sensory Memory: Evidence from MMN.

Frontiers in neuroscience

Tamakoshi S, Minoura N, Katayama J, Yagi A.
PMID: 27507931
Front Neurosci. 2016 Jul 26;10:347. doi: 10.3389/fnins.2016.00347. eCollection 2016.

In order to examine the encoding of partial silence included in a sound stimulus in neural representation, time flow of the sound representations was investigated using mismatch negativity (MMN), an ERP component that reflects neural representation in auditory sensory...

Cite
Tamakoshi S, Minoura N, Katayama J, et al. Entire Sound Representations Are Time-Compressed in Sensory Memory: Evidence from MMN. Front Neurosci. 2016;10:347doi: 10.3389/fnins.2016.00347.
Tamakoshi, S., Minoura, N., Katayama, J., & Yagi, A. (2016). Entire Sound Representations Are Time-Compressed in Sensory Memory: Evidence from MMN. Frontiers in neuroscience, 10347. https://doi.org/10.3389/fnins.2016.00347
Tamakoshi, Seiji, et al. "Entire Sound Representations Are Time-Compressed in Sensory Memory: Evidence from MMN." Frontiers in neuroscience vol. 10 (2016): 347. doi: https://doi.org/10.3389/fnins.2016.00347
Tamakoshi S, Minoura N, Katayama J, Yagi A. Entire Sound Representations Are Time-Compressed in Sensory Memory: Evidence from MMN. Front Neurosci. 2016 Jul 26;10:347. doi: 10.3389/fnins.2016.00347. eCollection 2016. PMID: 27507931; PMCID: PMC4960232.
Copy Download .nbib Format: NLM
Characterization of conformational deformation-coupled interaction between immunoglobulin G1 Fc glycoprotein and a low-affinity Fcγ receptor by deuteration-assisted small-angle neutron scattering.

Biochemistry and biophysics reports

Yogo R, Yanaka S, Yagi H, Martel A, Porcar L, Ueki Y, Inoue R, Sato N, Sugiyama M, Kato K.
PMID: 28955785
Biochem Biophys Rep. 2017 Aug 16;12:1-4. doi: 10.1016/j.bbrep.2017.08.004. eCollection 2017 Dec.

A recently developed integrative approach combining varied types of experimental data has been successfully applied to three-dimensional modelling of larger biomacromolecular complexes. Deuteration-assisted small-angle neutron scattering (SANS) plays a unique role in this approach by making it possible to...

Cite
Yogo R, Yanaka S, Yagi H, et al. Characterization of conformational deformation-coupled interaction between immunoglobulin G1 Fc glycoprotein and a low-affinity Fcγ receptor by deuteration-assisted small-angle neutron scattering. Biochem Biophys Rep. 2017;12:1-4doi: 10.1016/j.bbrep.2017.08.004.
Yogo, R., Yanaka, S., Yagi, H., Martel, A., Porcar, L., Ueki, Y., Inoue, R., Sato, N., Sugiyama, M., & Kato, K. (2017). Characterization of conformational deformation-coupled interaction between immunoglobulin G1 Fc glycoprotein and a low-affinity Fcγ receptor by deuteration-assisted small-angle neutron scattering. Biochemistry and biophysics reports, 121-4. https://doi.org/10.1016/j.bbrep.2017.08.004
Yogo, Rina, et al. "Characterization of conformational deformation-coupled interaction between immunoglobulin G1 Fc glycoprotein and a low-affinity Fcγ receptor by deuteration-assisted small-angle neutron scattering." Biochemistry and biophysics reports vol. 12 (2017): 1-4. doi: https://doi.org/10.1016/j.bbrep.2017.08.004
Yogo R, Yanaka S, Yagi H, Martel A, Porcar L, Ueki Y, Inoue R, Sato N, Sugiyama M, Kato K. Characterization of conformational deformation-coupled interaction between immunoglobulin G1 Fc glycoprotein and a low-affinity Fcγ receptor by deuteration-assisted small-angle neutron scattering. Biochem Biophys Rep. 2017 Aug 16;12:1-4. doi: 10.1016/j.bbrep.2017.08.004. eCollection 2017 Dec. PMID: 28955785; PMCID: PMC5613214.
Copy Download .nbib Format: NLM
Spin Polarization and Texture of the Fermi Arcs in the Weyl Fermion Semimetal TaAs.

Physical review letters

Xu SY, Belopolski I, Sanchez DS, Neupane M, Chang G, Yaji K, Yuan Z, Zhang C, Kuroda K, Bian G, Guo C, Lu H, Chang TR, Alidoust N, Zheng H, Lee CC, Huang SM, Hsu CH, Jeng HT, Bansil A, Neupert T, Komori F, Kondo T, Shin S, Lin H, Jia S, Hasan MZ.
PMID: 26991191
Phys Rev Lett. 2016 Mar 04;116(9):096801. doi: 10.1103/PhysRevLett.116.096801. Epub 2016 Mar 01.

A Weyl semimetal is a new state of matter that hosts Weyl fermions as quasiparticle excitations. The Weyl fermions at zero energy correspond to points of bulk-band degeneracy, called Weyl nodes, which are separated in momentum space and are...

Cite
Xu SY, Belopolski I, Sanchez DS, et al. Spin Polarization and Texture of the Fermi Arcs in the Weyl Fermion Semimetal TaAs. Phys Rev Lett. 2016;116(9):096801doi: 10.1103/PhysRevLett.116.096801.
Xu, S. Y., Belopolski, I., Sanchez, D. S., Neupane, M., Chang, G., Yaji, K., Yuan, Z., Zhang, C., Kuroda, K., Bian, G., Guo, C., Lu, H., Chang, T. R., Alidoust, N., Zheng, H., Lee, C. C., Huang, S. M., Hsu, C. H., Jeng, H. T., Bansil, A., Neupert, T., Komori, F., Kondo, T., Shin, S., Lin, H., Jia, S., & Hasan, M. Z. (2016). Spin Polarization and Texture of the Fermi Arcs in the Weyl Fermion Semimetal TaAs. Physical review letters, 116(9), 096801. https://doi.org/10.1103/PhysRevLett.116.096801
Xu, Su-Yang, et al. "Spin Polarization and Texture of the Fermi Arcs in the Weyl Fermion Semimetal TaAs." Physical review letters vol. 116,9 (2016): 096801. doi: https://doi.org/10.1103/PhysRevLett.116.096801
Xu SY, Belopolski I, Sanchez DS, Neupane M, Chang G, Yaji K, Yuan Z, Zhang C, Kuroda K, Bian G, Guo C, Lu H, Chang TR, Alidoust N, Zheng H, Lee CC, Huang SM, Hsu CH, Jeng HT, Bansil A, Neupert T, Komori F, Kondo T, Shin S, Lin H, Jia S, Hasan MZ. Spin Polarization and Texture of the Fermi Arcs in the Weyl Fermion Semimetal TaAs. Phys Rev Lett. 2016 Mar 04;116(9):096801. doi: 10.1103/PhysRevLett.116.096801. Epub 2016 Mar 01. PMID: 26991191.
Copy Download .nbib Format: NLM
Reply to "Comment on 'Bottom-up graphene-nanoribbon fabrication reveals chiral edges and enantioselectivity'".

ACS nano

Han P, Akagi K, Federici Canova F, Mutoh H, Shiraki S, Iwaya K, Weiss PS, Asao N, Hitosugi T.
PMID: 25916425
ACS Nano. 2015 Apr 28;9(4):3404-5. doi: 10.1021/acsnano.5b01687.

No abstract available.

Cite
Han P, Akagi K, Federici Canova F, et al. Reply to "Comment on 'Bottom-up graphene-nanoribbon fabrication reveals chiral edges and enantioselectivity'". ACS Nano. 2015;9(4):3404-5doi: 10.1021/acsnano.5b01687.
Han, P., Akagi, K., Federici Canova, F., Mutoh, H., Shiraki, S., Iwaya, K., Weiss, P. S., Asao, N., & Hitosugi, T. (2015). Reply to "Comment on 'Bottom-up graphene-nanoribbon fabrication reveals chiral edges and enantioselectivity'". ACS nano, 9(4), 3404-5. https://doi.org/10.1021/acsnano.5b01687
Han, Patrick, et al. "Reply to "Comment on 'Bottom-up graphene-nanoribbon fabrication reveals chiral edges and enantioselectivity'"." ACS nano vol. 9,4 (2015): 3404-5. doi: https://doi.org/10.1021/acsnano.5b01687
Han P, Akagi K, Federici Canova F, Mutoh H, Shiraki S, Iwaya K, Weiss PS, Asao N, Hitosugi T. Reply to "Comment on 'Bottom-up graphene-nanoribbon fabrication reveals chiral edges and enantioselectivity'". ACS Nano. 2015 Apr 28;9(4):3404-5. doi: 10.1021/acsnano.5b01687. PMID: 25916425.
Copy Download .nbib Format: NLM
Simeprevir/pegylated interferon/ribavirin triple therapy for recurrent hepatitis C after living donor liver transplantation.

Hepatology research : the official journal of the Japan Society of Hepatology

Shinoda M, Ebinuma H, Itano O, Yamagishi Y, Obara H, Kitago M, Nakamoto N, Hibi T, Yagi H, Abe Y, Matsubara K, Chu PS, Wakayama Y, Taniki N, Yamaguchi A, Amemiya R, Miyake R, Mizota T, Kanai T, Kitagawa Y.
PMID: 26854748
Hepatol Res. 2016 Oct;46(11):1118-1128. doi: 10.1111/hepr.12666. Epub 2016 Apr 22.

AIM: Simeprevir (SMV) is a protease inhibitor which demonstrates good tolerability and high antiviral response in patients with hepatitis C. The clinical outcomes of triple therapy using simeprevir, pegylated interferon and ribavirin (SMV/PEG IFN/RBV) for recurrent hepatitis C after...

Cite
Shinoda M, Ebinuma H, Itano O, et al. Simeprevir/pegylated interferon/ribavirin triple therapy for recurrent hepatitis C after living donor liver transplantation. Hepatol Res. 2016;46(11):1118-1128doi: 10.1111/hepr.12666.
Shinoda, M., Ebinuma, H., Itano, O., Yamagishi, Y., Obara, H., Kitago, M., Nakamoto, N., Hibi, T., Yagi, H., Abe, Y., Matsubara, K., Chu, P. S., Wakayama, Y., Taniki, N., Yamaguchi, A., Amemiya, R., Miyake, R., Mizota, T., Kanai, T., & Kitagawa, Y. (2016). Simeprevir/pegylated interferon/ribavirin triple therapy for recurrent hepatitis C after living donor liver transplantation. Hepatology research : the official journal of the Japan Society of Hepatology, 46(11), 1118-1128. https://doi.org/10.1111/hepr.12666
Shinoda, Masahiro, et al. "Simeprevir/pegylated interferon/ribavirin triple therapy for recurrent hepatitis C after living donor liver transplantation." Hepatology research : the official journal of the Japan Society of Hepatology vol. 46,11 (2016): 1118-1128. doi: https://doi.org/10.1111/hepr.12666
Shinoda M, Ebinuma H, Itano O, Yamagishi Y, Obara H, Kitago M, Nakamoto N, Hibi T, Yagi H, Abe Y, Matsubara K, Chu PS, Wakayama Y, Taniki N, Yamaguchi A, Amemiya R, Miyake R, Mizota T, Kanai T, Kitagawa Y. Simeprevir/pegylated interferon/ribavirin triple therapy for recurrent hepatitis C after living donor liver transplantation. Hepatol Res. 2016 Oct;46(11):1118-1128. doi: 10.1111/hepr.12666. Epub 2016 Apr 22. PMID: 26854748.
Copy Download .nbib Format: NLM
[No title available]

ACS medicinal chemistry letters

Kimura H, Okuda H, Ishiguro M, Arimitsu K, Makino A, Nishii R, Miyazaki A, Yagi Y, Watanabe H, Kawasaki I, Ono M, Saji H.
PMID: 28435529
ACS Med Chem Lett. 2017 Mar 20;8(4):418-422. doi: 10.1021/acsmedchemlett.6b00520. eCollection 2017 Apr 13.

In nonsmall-cell lung carcinoma patients, L858R mutation of epidermal growth factor receptor (EGFR) is often found, and molecular target therapy using EGFR tyrosine kinase inhibitors is effective for the patients. However, the treatment frequently develops drug resistance by secondary...

Cite
Kimura H, Okuda H, Ishiguro M, et al. . ACS Med Chem Lett. 2017;8(4):418-422doi: 10.1021/acsmedchemlett.6b00520.
Kimura, H., Okuda, H., Ishiguro, M., Arimitsu, K., Makino, A., Nishii, R., Miyazaki, A., Yagi, Y., Watanabe, H., Kawasaki, I., Ono, M., & Saji, H. (2017). . ACS medicinal chemistry letters, 8(4), 418-422. https://doi.org/10.1021/acsmedchemlett.6b00520
Kimura, Hiroyuki, et al. "." ACS medicinal chemistry letters vol. 8,4 (2017): 418-422. doi: https://doi.org/10.1021/acsmedchemlett.6b00520
Kimura H, Okuda H, Ishiguro M, Arimitsu K, Makino A, Nishii R, Miyazaki A, Yagi Y, Watanabe H, Kawasaki I, Ono M, Saji H. . ACS Med Chem Lett. 2017 Mar 20;8(4):418-422. doi: 10.1021/acsmedchemlett.6b00520. eCollection 2017 Apr 13. PMID: 28435529; PMCID: PMC5392762.
Copy Download .nbib Format: NLM
Prickle1 mutation causes planar cell polarity and directional cell migration defects associated with cardiac outflow tract anomalies and other structural birth defects.

Biology open

Gibbs BC, Damerla RR, Vladar EK, Chatterjee B, Wan Y, Liu X, Cui C, Gabriel GC, Zahid M, Yagi H, Szabo-Rogers HL, Suyama KL, Axelrod JD, Lo CW.
PMID: 26883626
Biol Open. 2016 Feb 16;5(3):323-35. doi: 10.1242/bio.015750.

Planar cell polarity (PCP) is controlled by a conserved pathway that regulates directional cell behavior. Here, we show that mutant mice harboring a newly described mutation termed Beetlejuice (Bj) in Prickle1 (Pk1), a PCP component, exhibit developmental phenotypes involving...

Cite
Gibbs BC, Damerla RR, Vladar EK, et al. Prickle1 mutation causes planar cell polarity and directional cell migration defects associated with cardiac outflow tract anomalies and other structural birth defects. Biol Open. 2016;5(3):323-35doi: 10.1242/bio.015750.
Gibbs, B. C., Damerla, R. R., Vladar, E. K., Chatterjee, B., Wan, Y., Liu, X., Cui, C., Gabriel, G. C., Zahid, M., Yagi, H., Szabo-Rogers, H. L., Suyama, K. L., Axelrod, J. D., & Lo, C. W. (2016). Prickle1 mutation causes planar cell polarity and directional cell migration defects associated with cardiac outflow tract anomalies and other structural birth defects. Biology open, 5(3), 323-35. https://doi.org/10.1242/bio.015750
Gibbs, Brian C, et al. "Prickle1 mutation causes planar cell polarity and directional cell migration defects associated with cardiac outflow tract anomalies and other structural birth defects." Biology open vol. 5,3 (2016): 323-35. doi: https://doi.org/10.1242/bio.015750
Gibbs BC, Damerla RR, Vladar EK, Chatterjee B, Wan Y, Liu X, Cui C, Gabriel GC, Zahid M, Yagi H, Szabo-Rogers HL, Suyama KL, Axelrod JD, Lo CW. Prickle1 mutation causes planar cell polarity and directional cell migration defects associated with cardiac outflow tract anomalies and other structural birth defects. Biol Open. 2016 Feb 16;5(3):323-35. doi: 10.1242/bio.015750. PMID: 26883626; PMCID: PMC4810743.
Copy Download .nbib Format: NLM
[SHORT OPINION ABOUT SURGEON'S WORK--LIFE BALANCE].

Nihon Geka Gakkai zasshi

Yagi K.
PMID: 27295767
Nihon Geka Gakkai Zasshi. 2016 Mar;117(2):97-8.

No abstract available.

Cite
Yagi K. [SHORT OPINION ABOUT SURGEON'S WORK--LIFE BALANCE]. Nihon Geka Gakkai Zasshi. 2016;117(2):97-8
Yagi, K. (2016). [SHORT OPINION ABOUT SURGEON'S WORK--LIFE BALANCE]. Nihon Geka Gakkai zasshi, 117(2), 97-8.
Yagi, Koichi. "[SHORT OPINION ABOUT SURGEON'S WORK--LIFE BALANCE]." Nihon Geka Gakkai zasshi vol. 117,2 (2016): 97-8.
Yagi K. [SHORT OPINION ABOUT SURGEON'S WORK--LIFE BALANCE]. Nihon Geka Gakkai Zasshi. 2016 Mar;117(2):97-8. Japanese. PMID: 27295767.
Copy Download .nbib Format: NLM
Albumin-bound paclitaxel for the treatment of refractory or relapsed small-cell lung cancer.

Molecular and clinical oncology

Yoshida H, Kim YH, Ozasa H, Nagai H, Sakamori Y, Nakaoku T, Yagi Y, Tsuji T, Nomizo T, Mishima M.
PMID: 27330801
Mol Clin Oncol. 2016 Jul;5(1):213-215. doi: 10.3892/mco.2016.887. Epub 2016 May 06.

Since nanoparticle albumin-bound (nab)-paclitaxel exerts clinically meaningful antitumor effects on various malignancies, including breast, gastric and non-small-cell lung cancer, we hypothesized that treatment with nab-paclitaxel may also be beneficial for patients with small-cell lung cancer (SCLC). We herein evaluated...

Cite
Yoshida H, Kim YH, Ozasa H, et al. Albumin-bound paclitaxel for the treatment of refractory or relapsed small-cell lung cancer. Mol Clin Oncol. 2016;5(1):213-215doi: 10.3892/mco.2016.887.
Yoshida, H., Kim, Y. H., Ozasa, H., Nagai, H., Sakamori, Y., Nakaoku, T., Yagi, Y., Tsuji, T., Nomizo, T., & Mishima, M. (2016). Albumin-bound paclitaxel for the treatment of refractory or relapsed small-cell lung cancer. Molecular and clinical oncology, 5(1), 213-215. https://doi.org/10.3892/mco.2016.887
Yoshida, Hironori, et al. "Albumin-bound paclitaxel for the treatment of refractory or relapsed small-cell lung cancer." Molecular and clinical oncology vol. 5,1 (2016): 213-215. doi: https://doi.org/10.3892/mco.2016.887
Yoshida H, Kim YH, Ozasa H, Nagai H, Sakamori Y, Nakaoku T, Yagi Y, Tsuji T, Nomizo T, Mishima M. Albumin-bound paclitaxel for the treatment of refractory or relapsed small-cell lung cancer. Mol Clin Oncol. 2016 Jul;5(1):213-215. doi: 10.3892/mco.2016.887. Epub 2016 May 06. PMID: 27330801; PMCID: PMC4906929.
Copy Download .nbib Format: NLM
Remarkable stimulation of emission quenching on a clay surface.

Langmuir : the ACS journal of surfaces and colloids

Sato K, Matsubara K, Hagiwara S, Saito K, Yagi M, Takagi S, Yui T.
PMID: 25540843
Langmuir. 2015 Jan 13;31(1):27-31. doi: 10.1021/la504597t. Epub 2014 Dec 31.

Tetra-cationic pyrene derivative (Py(4+)) and tris(bipyridine)ruthenium(II) (Ru(2+)) were hybridized onto the surface of a synthesized clay. We observed the remarkable stimulation of excited Py(4+) emission quenching on the clay surface, with a very large apparent quenching rate constant (kq...

Cite
Sato K, Matsubara K, Hagiwara S, et al. Remarkable stimulation of emission quenching on a clay surface. Langmuir. 2014;31(1):27-31doi: 10.1021/la504597t.
Sato, K., Matsubara, K., Hagiwara, S., Saito, K., Yagi, M., Takagi, S., & Yui, T. (2015). Remarkable stimulation of emission quenching on a clay surface. Langmuir : the ACS journal of surfaces and colloids, 31(1), 27-31. https://doi.org/10.1021/la504597t
Sato, Keita, et al. "Remarkable stimulation of emission quenching on a clay surface." Langmuir : the ACS journal of surfaces and colloids vol. 31,1 (2015): 27-31. doi: https://doi.org/10.1021/la504597t
Sato K, Matsubara K, Hagiwara S, Saito K, Yagi M, Takagi S, Yui T. Remarkable stimulation of emission quenching on a clay surface. Langmuir. 2015 Jan 13;31(1):27-31. doi: 10.1021/la504597t. Epub 2014 Dec 31. PMID: 25540843.
Copy Download .nbib Format: NLM
Patents and literature.

Applied biochemistry and biotechnology

Smith JA, Luenser SJ, Olson NF, Magee EL, Olivieri R, Viglia A, Degen L, Angelini L, Fascetti E, Miwa N, Masuda Y, Kawarabuki S, Sai T, Saito T, Busby MG, Hartwig DW, Heady R, Yagi Y, Kouno K, Inui T, Marshall JJ, Thomson AR, Miles BJ, Caygill JC, Moore DJ, Nakamura K, Nankai S, Iijima T, Ooshima Y, Baldeschwieler JD, Gamble RC, Mauk MR, Shen TY, Ponpipom MM, Khachatourians GG, Zaffaroni P, Senni A, Formiconi L, Blair JE, Davis LT, Cabane B, Vergnault J, Volesky B, Tsezos M, Bull FG, Messing RA, Ahnell JE, Chen LF, Gong CS, Tsao GT, Katsumata R, Green S, Leiser RS, Fedde PA, Ghosh S, Henry MP, Klass DL, Uemura Y, Arimura H, Morise H, Funakoshi S, Suyama T, Lützen NW, Kita DA, Fenton DM, Maclennan DG, Ousby JC, Owen TR, Steer DC, Araujo FJ, Calderon IL, Diaz IL, Olmedo C, Rebeller M, Yout P, Lonchamp D, Mynatt RL, Berg A, Eckmayer Z, Maselli JA, Horwath RO, Gotou E, Satou K, Wu RJ, Bahl CP, Narang SA, Hershberger CL, Baxter JD, Roberts JL, Seeburg PH, Goodman HM, Tsuchida T.
PMID: 24234462
Appl Biochem Biotechnol. 1982 Nov;7(6):497-510. doi: 10.1007/BF02799180.

No abstract available.

Cite
Smith JA, Luenser SJ, Olson NF, et al. Patents and literature. Appl Biochem Biotechnol. 1982;7(6):497-510doi: 10.1007/BF02799180.
Smith, J. A., Luenser, S. J., Olson, N. F., Magee, E. L., Olivieri, R., Viglia, A., Degen, L., Angelini, L., Fascetti, E., Miwa, N., Masuda, Y., Kawarabuki, S., Sai, T., Saito, T., Busby, M. G., Hartwig, D. W., Heady, R., Yagi, Y., Kouno, K., Inui, T., Marshall, J. J., Thomson, A. R., Miles, B. J., Caygill, J. C., Moore, D. J., Nakamura, K., Nankai, S., Iijima, T., Ooshima, Y., Baldeschwieler, J. D., Gamble, R. C., Mauk, M. R., Shen, T. Y., Ponpipom, M. M., Khachatourians, G. G., Zaffaroni, P., Senni, A., Formiconi, L., Blair, J. E., Davis, L. T., Cabane, B., Vergnault, J., Volesky, B., Tsezos, M., Bull, F. G., Messing, R. A., Ahnell, J. E., Chen, L. F., Gong, C. S., Tsao, G. T., Katsumata, R., Green, S., Leiser, R. S., Fedde, P. A., Ghosh, S., Henry, M. P., Klass, D. L., Uemura, Y., Arimura, H., Morise, H., Funakoshi, S., Suyama, T., Lützen, N. W., Kita, D. A., Fenton, D. M., Maclennan, D. G., Ousby, J. C., Owen, T. R., Steer, D. C., Araujo, F. J., Calderon, I. L., Diaz, I. L., Olmedo, C., Rebeller, M., Yout, P., Lonchamp, D., Mynatt, R. L., Berg, A., Eckmayer, Z., Maselli, J. A., Horwath, R. O., Gotou, E., Satou, K., Wu, R. J., Bahl, C. P., Narang, S. A., Hershberger, C. L., Baxter, J. D., Roberts, J. L., Seeburg, P. H., Goodman, H. M., & Tsuchida, T. (1982). Patents and literature. Applied biochemistry and biotechnology, 7(6), 497-510. https://doi.org/10.1007/BF02799180
Smith, J A, et al. "Patents and literature." Applied biochemistry and biotechnology vol. 7,6 (1982): 497-510. doi: https://doi.org/10.1007/BF02799180
Smith JA, Luenser SJ, Olson NF, Magee EL, Olivieri R, Viglia A, Degen L, Angelini L, Fascetti E, Miwa N, Masuda Y, Kawarabuki S, Sai T, Saito T, Busby MG, Hartwig DW, Heady R, Yagi Y, Kouno K, Inui T, Marshall JJ, Thomson AR, Miles BJ, Caygill JC, Moore DJ, Nakamura K, Nankai S, Iijima T, Ooshima Y, Baldeschwieler JD, Gamble RC, Mauk MR, Shen TY, Ponpipom MM, Khachatourians GG, Zaffaroni P, Senni A, Formiconi L, Blair JE, Davis LT, Cabane B, Vergnault J, Volesky B, Tsezos M, Bull FG, Messing RA, Ahnell JE, Chen LF, Gong CS, Tsao GT, Katsumata R, Green S, Leiser RS, Fedde PA, Ghosh S, Henry MP, Klass DL, Uemura Y, Arimura H, Morise H, Funakoshi S, Suyama T, Lützen NW, Kita DA, Fenton DM, Maclennan DG, Ousby JC, Owen TR, Steer DC, Araujo FJ, Calderon IL, Diaz IL, Olmedo C, Rebeller M, Yout P, Lonchamp D, Mynatt RL, Berg A, Eckmayer Z, Maselli JA, Horwath RO, Gotou E, Satou K, Wu RJ, Bahl CP, Narang SA, Hershberger CL, Baxter JD, Roberts JL, Seeburg PH, Goodman HM, Tsuchida T. Patents and literature. Appl Biochem Biotechnol. 1982 Nov;7(6):497-510. doi: 10.1007/BF02799180. PMID: 24234462.
Copy Download .nbib Format: NLM
Showing 25 to 36 of 1829 entries